Medivir AB Statistics

Total Valuation

Medivir AB has a market cap or net worth of GBP 23.81 million. The enterprise value is 17.69 million.

Market Cap	23.81M
Enterprise Value	17.69M

Important Dates

The next estimated earnings date is Tuesday, February 18, 2025.

Earnings Date	Feb 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+84.59%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	84.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	7.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.06
EV / Sales	34.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.43

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.07.

Current Ratio	1.84
Quick Ratio	1.84
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	-133.35

Financial Efficiency

Return on equity (ROE) is -87.81% and return on invested capital (ROIC) is -52.90%.

Return on Equity (ROE)	-87.81%
Return on Assets (ROA)	-40.02%
Return on Capital (ROIC)	-52.90%
Revenue Per Employee	51,737
Profits Per Employee	-860,113
Employee Count	10
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.67% in the last 52 weeks. The beta is 0.33, so Medivir AB's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-27.67%
50-Day Moving Average	6.52
200-Day Moving Average	26.29
Relative Strength Index (RSI)	25.93
Average Volume (20 Days)	3,717

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medivir AB had revenue of GBP 517,368 and -8.60 million in losses. Loss per share was -0.08.

Revenue	517,368
Gross Profit	-6.62M
Operating Income	-8.96M
Pretax Income	-8.60M
Net Income	-8.60M
EBITDA	-8.95M
EBIT	-8.96M
Loss Per Share	-0.08

Full Income Statement

Balance Sheet

The company has 6.80 million in cash and 698,848 in debt, giving a net cash position of 6.11 million.

Cash & Cash Equivalents	6.80M
Total Debt	698,848
Net Cash	6.11M
Net Cash Per Share	n/a
Equity (Book Value)	10.43M
Book Value Per Share	0.09
Working Capital	3.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.31 million and capital expenditures 22,069, giving a free cash flow of -7.29 million.

Operating Cash Flow	-7.31M
Capital Expenditures	22,069
Free Cash Flow	-7.29M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,731.17%
Pretax Margin	-1,662.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Medivir AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-84.59%
Shareholder Yield	-84.59%
Earnings Yield	-36.12%
FCF Yield	-30.61%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medivir AB has an Altman Z-Score of -4.37. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.37
Piotroski F-Score	n/a